Neurologic disorders in HIV-positive orphans: 10 years of follow up.

Objective: Neuropsychic manifestations of AIDS are still noticeable especially in developing countries. The aim of this short communication is to describe psychological, behavioral and neurologic disorders caused by either HIV-related disorders, or drug related toxicities in HIV-infected children from Cambodia (Phnom Penh, Sihanoukville) treated during 10 years with highly active antiretroviral therapy (HAART).

Methods: One hundred and thirty seven (137) HIV-positive children (age 2-19 years) treated with HAART since 2003 (6-10 years follow up) have been analyzed concerning opportunistic infections, other co-infections, renal parameters, hematologic parameters, chest X-ray, antiretroviral treatment, anti-tuberculotics and antibiotics treatment.

Tropical neuroinfections in south sudanese rural hospitals - analysis of 8,709 patients.

Objective: Infections involving the central nervous system have very serious consequences and affect thousands of people in Africa. Despite the availability of new antibiotics and vaccines, neuroinfections act as dangerous and life-threatening conditions. The most frequent neuroinfections which are of the greatest importance for public health systems are viral diseases (such as HIV, encephalitis, poliomyelitis, rabies), bacterial diseases (bacterial meningitis, neurological complications of leprosy and tuberculosis) and parasitic infections (cerebral malaria, sleeping sickness, trypanosomiasis, schistosomiasis, toxoplasmosis etc.

The psychosocial conditions and intensified education that may affect school performance of HIV/AIDS orphaned children on antiretroviral drugs.

Objective: This study begins with interpreting basic academic results from the House of Family (HOF) comprehensive project for HIV/AIDS orphaned children. We reviewed school performance during the academic period from 2007 to 2012.

Methods: All the children in the HOF project have vertically acquired HIV infection, with approximately 90% being with AIDS/Clinical Stage C at the time of admission.